Castle Biosciences (CSTL) Net Equity Issued and Repurchased (2019 - 2020)

Castle Biosciences (CSTL) posted Net Equity Issued and Repurchased of $250.5 million for Q4 2020, up 2411.9% sequentially from $10.0 million in Q3 2020, and up 6263525.0% YoY from N/an in Q1 2020.

Castle Biosciences (CSTL) Net Equity Issued and Repurchased (2019 - 2020) Analysis & Trends

Castle Biosciences has reported Net Equity Issued and Repurchased for 2 years, with the latest figure at $250.5 million in Q4 2020.

  • Quarterly Net Equity Issued and Repurchased rose 6263525.0% year-over-year to $250.5 million in Q4 2020, while the trailing twelve-month figure through Dec 2021 was $260.5 million (down 20.2% YoY) and the FY2020 annual result came in at $330.0 million, up 400.59% from the prior year.
  • Net Equity Issued and Repurchased rose to $250.5 million in Q4 2020 per CSTL's latest filing, from $10.0 million in the prior quarter.
  • Over five years, Net Equity Issued and Repurchased peaked at $250.5 million in Q4 2020 and troughed at -$4000.0 in Q4 2019.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Thermo Fisher Scientific 213.40 Bn 209.33 Bn 8.34 Bn -
2 Danaher 139.94 Bn 135.59 Bn 3.61 Bn -
3 Idexx Laboratories 46.03 Bn 45.83 Bn 779.09 Mn -
4 Agilent Technologies 39.69 Bn 37.88 Bn 990.00 Mn -
5 Iqvia Holdings 39.32 Bn 37.24 Bn 1.44 Bn -
6 Natera 38.47 Bn 37.37 Bn 696.04 Mn -
7 Illumina 29.98 Bn 28.82 Bn 770.00 Mn -
8 Mettler Toledo International 28.57 Bn 28.52 Bn 650.22 Mn -
9 Quest Diagnostics 26.21 Bn 25.58 Bn 1.03 Bn -
10 Castle Biosciences 923.37 Mn 656.55 Mn 79.85 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2020 250.54 Mn
Dec 31, 2020 250.54 Mn
Sep 30, 2020 9.97 Mn
Sep 30, 2020 9.97 Mn
Dec 31, 2019 -4,000.00
Dec 31, 2019 -4,000.00
Sep 30, 2019 65.94 Mn
Sep 30, 2019 65.94 Mn